The effect of SGLT2 inhibitors on drugnaive obese type 2 diabetes mellitus patients

被引：0
|
作者：
Chikazawa, Shinji [1 ]
Matsuhashi, Yuki [2 ]
Tando, Yusuke [2 ]
Daimon, Makoto [2 ]
机构：
[1] Tsugaru Gen Hosp, Goshogawara, Aomori, Japan
[2] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-38
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [21] The pharmacokinetics and pharmacodynamics of SGLT2 inhibitors for type 2 diabetes mellitus: the latest developments
    Garcia-Ropero, Alvaro
    Badimon, Juan J.
    Santos-Gallego, Carlos G.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (12) : 1287 - 1302
  • [22] Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment
    Rizzo, Maria Rosaria
    Di Meo, Irene
    Polito, Rita
    Auriemma, Maria Chiara
    Gambardella, Antonio
    di Mauro, Gabriella
    Capuano, Annalisa
    Paolisso, Giuseppe
    [J]. PHARMACOLOGICAL RESEARCH, 2022, 176
  • [23] POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUS
    Handelsman, Yehuda
    [J]. ENDOCRINE PRACTICE, 2015, 21 (09) : 1054 - 1065
  • [24] Why are SGLT2 inhibitors a good choice in the management of Type 2 Diabetes Mellitus?
    Ghazanfar, Nhila
    [J]. WORLD FAMILY MEDICINE, 2021, 19 (07): : 86 - 88
  • [25] The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
    Fattah, Hadi
    Vallon, Volker
    [J]. DRUGS, 2018, 78 (07) : 717 - 726
  • [26] The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
    Hadi Fattah
    Volker Vallon
    [J]. Drugs, 2018, 78 : 717 - 726
  • [27] Effect of SGLT2 Inhibitors and Metformin on Inflammatory and Prognostic Biomarkers in Type 2 Diabetes Patients
    Cao, Yang
    Liang, Ning
    Liu, Ting
    Fang, Jingai
    Zhang, Xiaodong
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (04) : 530 - 547
  • [28] The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
    Sanchez-Briales, Paula
    Vidas, Maria Marques
    Lopez-Sanchez, Paula
    Lopez-Illazquez, Maria Victoria
    Martin-Testillano, Lucia
    Vedat-Ali, Aylin
    Portoles, Jose
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [29] SGLT2 Inhibitors: Effect on Myocardial Infarction and Stroke in Type 2 Diabetes
    Mukhopadhyay, Pradip
    Sanyal, Debmalya
    Chatterjee, Purushottam
    Pandit, Kaushik
    Ghosh, Sujoy
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (08): : 2134 - 2140
  • [30] SGLT2 Inhibitors for the Prevention of Kidney Failure in Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2019, 15 (07): : 663 - 664
12345